Organovo Holdings Inc
NASDAQ:ONVO
Organovo Holdings Inc
NASDAQ:ONVO
Price:
1.87
USD
-8.33%
Market Closed
Market Cap:
$3.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Organovo Holdings Inc
NASDAQ:ONVO
|
US |
|
Shoe Carnival Inc
NASDAQ:SCVL
|
US |
|
Chemcon Speciality Chemicals Ltd
NSE:CHEMCON
|
IN |
|
Z
|
Zinka Logistics Solutions Ltd
NSE:BLACKBUCK
|
IN |
|
H
|
Hybrid Technologies Co Ltd
TSE:4260
|
JP |
|
R
|
Real Brokerage Inc
NASDAQ:REAX
|
CA |
|
C
|
Cera Sanitaryware Ltd
NSE:CERA
|
IN |
|
Frontier Services Group Ltd
HKEX:500
|
HK |
|
C
|
Club Hipico de Santiago SA
SGO:HIPICO
|
CL |
|
H
|
Hampton Hill Mining NL
ASX:HHM
|
AU |
|
Taiyuan Heavy Industry Co Ltd
SSE:600169
|
CN |
|
Raymond Ltd
NSE:RAYMOND
|
IN |
|
T
|
Toya SA
WSE:TOA
|
PL |
|
T
|
Tazmo Co Ltd
TSE:6266
|
JP |
|
A
|
Acarix AB
STO:ACARIX
|
SE |
Relative Value
The Relative Value of one
ONVO
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 1.87 USD,
Organovo Holdings Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ONVO Relative Value
HIDDEN
Multiples Across Competitors
ONVO Competitors Multiples
Organovo Holdings Inc Competitors
Organovo Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Organovo Holdings Inc
NASDAQ:ONVO
|
3.2m USD | 26.1 | -0.3 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 33.9 | 11.2 | 14.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
